Nucleai, an AI-powered spatial biology company, will present two abstracts at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting. The presentations will detail how Nucleai's AI-driven ...
Ideaya Biosciences (IDYA) announced Phase 1 expansion data for IDE397 in methylthioadenosine phosphorylase, or MTAP-deletion urothelial cancer, ...
The Company's liquid biopsy platform ... Poster presentation on Lobular Breast Cancer Research: BioMark's abstract entitled "Targeted Human Plasma Metabolomics for Lobular Breast Cancer Biomarker ...
ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") , an AI-driven biotherapeutic research and technology company, announces the details of its upcoming TECHDAY event on Friday, November 15, 2024, ...
The Washington Post on MSN12d
The most powerful fashion designer you don’t know aboutChitose Abe of Sacai is the most powerful fashion designer you don’t know about, thanks to her ability to fuse street and ...
Operator Good afternoon, everyone, and welcome to Gilead's third quarter 2024 earnings conference call. My name is Rebecca, and I'll be your host for today. In a moment, we'll begin with our prepared ...
Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsDaniel O'Day - Chairman, Chief ...
Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ET. Company Participants. Chris Taylor - Vice President, Investor Relations and ...
Abstract Security has raised $15 million in an oversubscribed Series A funding round led by Munich Re Ventures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback